VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,914,585 | -57.0% | 311,055 | +12.6% | 0.00% | -50.0% |
| Q2 2023 | $6,774,033 | -4.1% | 276,153 | -9.0% | 0.00% | 0.0% |
| Q1 2023 | $7,063,352 | -9.1% | 303,539 | -1.1% | 0.00% | -33.3% |
| Q4 2022 | $7,768,000 | -30.2% | 306,925 | -46.8% | 0.00% | -25.0% |
| Q3 2022 | $11,132,000 | +38.4% | 577,377 | +82.8% | 0.00% | +33.3% |
| Q2 2022 | $8,045,000 | +1652.7% | 315,898 | +1667.2% | 0.00% | – |
| Q1 2022 | $459,000 | -23.0% | 17,876 | +25.6% | 0.00% | – |
| Q4 2021 | $596,000 | +2.6% | 14,232 | +6.6% | 0.00% | – |
| Q3 2021 | $581,000 | -9.4% | 13,352 | -1.5% | 0.00% | – |
| Q2 2021 | $641,000 | -7.0% | 13,552 | +0.8% | 0.00% | – |
| Q1 2021 | $689,000 | – | 13,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |